3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector [Soliqua]
RxNorm concept 1859000, branded drug (sbd). Prescribable name: Soliqua 100/33 in 3 ML Pen Injector.
- RxCUI
- 1859000
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1859000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Soliqua 100/33 per 3 ML Pen Injector
Related concepts
- insulin glargine 100 UNT/ML (SCDC, consists of)
- lixisenatide 0.033 MG/ML (SCDC, consists of)
- insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML [Soliqua] (SBDC, consists of)
- Pen Injector (DF, has dose form)
- Soliqua (BN, has ingredient)
- 3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector (SCD, tradename of)
Linked data
NDCs
- 00024576101
- 00024576102
- 00024576105
- 00024576302
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1859000 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1859000 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1859000. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.